{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:08:17Z","timestamp":1790788097028,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.fct.2022.113321","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T04:17:48Z","timestamp":1659413868000},"page":"113321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Vitamin C-induced competitive binding of HIF-1\u03b1 and p53 to ubiquitin E3 ligase CBL contributes to anti-breast cancer progression through p53 deacetylation"],"prefix":"10.1016","volume":"168","author":[{"given":"Yan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Y.","family":"Zaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2022.113321_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tibs.2015.04.007","article-title":"The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression","volume":"40","author":"Amelio","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.fct.2022.113321_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10120499","article-title":"Mitochondrial VDAC1 silencing leads to metabolic rewiring and the reprogramming of tumour cells into advanced differentiated states","volume":"10","author":"Arif","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.fct.2022.113321_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/ijc.29519","article-title":"HIF-1 at the crossroads of hypoxia, inflammation, and cancer","volume":"138","author":"Balamurugan","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.fct.2022.113321_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.fct.2022.113321_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10456-020-09707-z","article-title":"Decylubiquinone suppresses breast cancer growth and metastasis by inhibiting angiogenesis via the ROS\/p53\/Bai1 signaling pathway","volume":"23","author":"Cao","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.fct.2022.113321_bib7","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fct.2022.113321_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tcb.2020.02.001","article-title":"Quality control and turnover of endoplasmic reticulum","volume":"30","author":"Chino","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.fct.2022.113321_bib9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.tcb.2018.04.001","article-title":"Vitamin C in stem cell reprogramming and cancer","volume":"28","author":"Cimmino","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.fct.2022.113321_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218397","article-title":"Why vitamin C could Be an excellent complementary remedy to conventional therapies for breast cancer","volume":"21","author":"Codini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fct.2022.113321_bib12","first-page":"1512","article-title":"Global signatures of protein and mRNA expression levels","volume":"5","author":"de Sousa Abreu","year":"2009","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.fct.2022.113321_bib13","first-page":"443","article-title":"Ascorbic acid: chemistry, biology and the treatment of cancer","volume":"1826","author":"Du","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.fct.2022.113321_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41419-020-02952-6","article-title":"A miR-210-3p regulon that controls the Warburg effect by modulating HIF-1alpha and p53 activity in triple-negative breast cancer","volume":"11","author":"Du","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.fct.2022.113321_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.tcb.2013.06.001","article-title":"Transcriptional control of cancer metastasis","volume":"23","author":"Ell","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.fct.2022.113321_bib16","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/emboj\/18.7.1905","article-title":"Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP\/p300","volume":"18","author":"Ema","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.fct.2022.113321_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biopha.2016.12.056","article-title":"Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma","volume":"86","author":"Fischer","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fct.2022.113321_bib19","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.fct.2022.113321_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/onc.2011.270","article-title":"MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63","volume":"31","author":"Gamble","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.fct.2022.113321_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/nu11122997","article-title":"Vitamin C inhibits triple-negative breast cancer metastasis by affecting the expression of YAP1 and synaptopodin 2","volume":"11","author":"Gan","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.fct.2022.113321_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.toxlet.2016.06.019","article-title":"Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells","volume":"258","author":"Gong","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2022.113321_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41574-018-0096-z","article-title":"The role of hypoxia-inducible factors in metabolic diseases","volume":"15","author":"Gonzalez","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.fct.2022.113321_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101356","article-title":"Hydrogen sulfide attenuates cigarette smoke-induced airway remodeling by upregulating SIRT1 signaling pathway","volume":"28","author":"Guan","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.fct.2022.113321_bib27","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1093\/hmg\/ddm052","article-title":"Dangerous habits of a security guard: the two faces of p53 as a drug target","volume":"1","author":"Gudkov","year":"2007","journal-title":"Hum Mol Genet 16 Spec No"},{"key":"10.1016\/j.fct.2022.113321_bib28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejca.2014.02.013","article-title":"Vitamin C and survival among women with breast cancer: a meta-analysis","volume":"50","author":"Harris","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.fct.2022.113321_bib29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/djy149","article-title":"Auranofin\/Vitamin C: a novel drug combination targeting triple-negative breast cancer","volume":"111","author":"Hatem","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.fct.2022.113321_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032607","article-title":"Principles of translational control","volume":"11","author":"Hershey","year":"2019","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.fct.2022.113321_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","article-title":"Structural biology of the tumor suppressor p53","volume":"77","author":"Joerger","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.fct.2022.113321_bib32","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1158\/0008-5472.CAN-08-3221","article-title":"Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma","volume":"69","author":"Kiessling","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.fct.2022.113321_bib33","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.freeradbiomed.2012.07.079","article-title":"Enhanced antitumor activity of vitamin C via p53 in cancer cells","volume":"53","author":"Kim","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.fct.2022.113321_bib35","article-title":"The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma","volume":"1","author":"Lakoma","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.fct.2022.113321_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad3740","article-title":"Antioxidants can increase melanoma metastasis in mice","volume":"7","author":"Le Gal","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.fct.2022.113321_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emm.2004.1","article-title":"Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions","volume":"36","author":"Lee","year":"2004","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.fct.2022.113321_bib39","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/carcin\/bgp196","article-title":"Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha","volume":"30","author":"Lee","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.fct.2022.113321_bib40","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3892\/ijo.2015.2840","article-title":"SIAH1-induced p34SEI-1 polyubiquitination\/degradation mediates p53 preferential vitamin C cytotoxicity","volume":"46","author":"Lee","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.fct.2022.113321_bib41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.21873\/anticanres.13172","article-title":"Effect of high-dose vitamin C combined with anti-cancer treatment on breast cancer cells","volume":"39","author":"Lee","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.fct.2022.113321_bib42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/25292","article-title":"Genetic instabilities in human cancers","volume":"396","author":"Lengauer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.fct.2022.113321_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","article-title":"p53: 800 million years of evolution and 40 years of discovery","volume":"20","author":"Levine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.fct.2022.113321_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jnutbio.2009.06.004","article-title":"Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1alpha","volume":"21","author":"Li","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.fct.2022.113321_bib45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13045-021-01146-7","article-title":"Protein degradation technology: a strategic paradigm shift in drug discovery","volume":"14","author":"Li","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.fct.2022.113321_bib46","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.7150\/thno.30988","article-title":"Hypoxia-induced feedback of HIF-1alpha and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.fct.2022.113321_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","article-title":"HIF-1 and HIF-2 transcription factors--similar but not identical","volume":"29","author":"Loboda","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.fct.2022.113321_bib49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.21873\/cgp.20227","article-title":"Stem-like cells from invasive breast carcinoma cell line MDA-MB-231 express a distinct set of Eph receptors and ephrin ligands","volume":"17","author":"Lucero","year":"2020","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.fct.2022.113321_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2017.09.008","article-title":"Pharmacologic ascorbate induces neuroblastoma cell death by hydrogen peroxide mediated DNA damage and reduction in cancer cell glycolysis","volume":"113","author":"Ma","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.fct.2022.113321_bib51","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1093\/nar\/gkz766","article-title":"HIF-transcribed p53 chaperones HIF-1alpha","volume":"47","author":"Madan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.fct.2022.113321_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20150517","article-title":"Regulation of the p53 response and its relationship to cancer","volume":"469","author":"Meek","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.fct.2022.113321_bib54","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000950","article-title":"Posttranslational modification of p53: cooperative integrators of function","volume":"1","author":"Meek","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.fct.2022.113321_bib55","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.1073\/pnas.0506230102","article-title":"An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival","volume":"102","author":"Miller","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fct.2022.113321_bib56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41568-019-0135-7","article-title":"J. Targeting cancer vulnerabilities with high-dose vitamin C","volume":"19","author":"Ngo","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.fct.2022.113321_bib57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2017.03.013","article-title":"Reviving the guardian of the genome: small molecule activators of p53","volume":"178","author":"Nguyen","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.fct.2022.113321_bib58","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jcp.20406","article-title":"Mdm2 and HIF-1alpha interaction in tumor cells during hypoxia","volume":"204","author":"Nieminen","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.fct.2022.113321_bib59","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1182\/blood-2010-09-307637","article-title":"Vitamin C is dispensable for oxygen sensing in vivo","volume":"117","author":"Nytko","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.fct.2022.113321_bib60","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10549-011-1851-1","article-title":"Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer","volume":"133","author":"Panis","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.fct.2022.113321_bib61","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature12998","article-title":"The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells","volume":"507","author":"Paolino","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.fct.2022.113321_bib62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature15726","article-title":"Oxidative stress inhibits distant metastasis by human melanoma cells","volume":"527","author":"Piskounova","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.fct.2022.113321_bib63","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.aax3769","article-title":"Cellular quality control by the ubiquitin-proteasome system and autophagy","volume":"366","author":"Pohl","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.fct.2022.113321_bib64","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1089\/ars.2011.4367","article-title":"The tumor microenvironment: characterization, redox considerations, and novel approaches for reactive oxygen species-targeted gene therapy","volume":"19","author":"Policastro","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.fct.2022.113321_bib65","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1172\/JCI137560","article-title":"Hypoxia-inducible factors and obstructive sleep apnea","volume":"130","author":"Prabhakar","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fct.2022.113321_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5202606","article-title":"Effect of high-dose vitamin C infusion in a glucose-6-phosphate dehydrogenase-deficient patient","author":"Quinn","year":"2017","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.fct.2022.113321_bib68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/his.13446","article-title":"Invasion in breast lesions: the role of the epithelial-stroma barrier","volume":"72","author":"Rakha","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.fct.2022.113321_bib69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aaf4405","article-title":"Hypoxic control of metastasis","volume":"352","author":"Rankin","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.fct.2022.113321_bib70","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.14.1.34","article-title":"Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha","volume":"14","author":"Ravi","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.fct.2022.113321_bib71","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.306.6881.841","article-title":"Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency","volume":"306","author":"Rees","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.fct.2022.113321_bib72","doi-asserted-by":"crossref","first-page":"16187","DOI":"10.1074\/jbc.M702203200","article-title":"J. In cultured astrocytes, p53 and MDM2 do not alter hypoxia-inducible factor-1alpha function regardless of the presence of DNA damage","volume":"282","author":"Rempe","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2022.113321_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2019.03.026","article-title":"Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin","volume":"136","author":"Rubis","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.fct.2022.113321_bib74","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/1078-0432.CCR-19-0694","article-title":"Alterations in the transcriptional programs of myeloma cells and the microenvironment during extramedullary progression affect proliferation and immune evasion","volume":"26","author":"Ryu","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.fct.2022.113321_bib75","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1038\/s41598-018-23714-7","article-title":"Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression","volume":"8","author":"Sant","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2022.113321_bib76","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.fct.2022.113321_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.fct.2022.113321_bib78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.fct.2022.113321_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","article-title":"Hypoxia-inducible factor 1 and cardiovascular disease","volume":"76","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.fct.2022.113321_bib80","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1038\/s41467-019-12801-6","article-title":"YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression","volume":"10","author":"Shi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fct.2022.113321_bib81","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.fct.2022.113321_bib82","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.7150\/thno.35219","article-title":"Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK\/ERK and PI3K\/AKT pathways via distinct mechanisms","volume":"9","author":"Su","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.fct.2022.113321_bib83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13046-021-01831-y","article-title":"Vitamin C sensitizes BRAF(V600E) thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK\/ERK signal by PLX4032","volume":"40","author":"Su","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.fct.2022.113321_bib84","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182091","article-title":"Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia","volume":"217","author":"Tang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.fct.2022.113321_bib85","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/BJ20050892","article-title":"c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses","volume":"391","author":"Thien","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.fct.2022.113321_bib86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10456-016-9528-3","article-title":"BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53\/MDM2-mediated HIF-1alpha proteasomal degradation","volume":"20","author":"Thirusangu","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.fct.2022.113321_bib87","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.fct.2022.113321_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-020-00245-6","article-title":"Beyond K48 and K63: non-canonical protein ubiquitination","volume":"26","author":"Tracz","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.fct.2022.113321_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/srep13896","article-title":"Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress","volume":"5","author":"Uetaki","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2022.113321_bib90","first-page":"2138","article-title":"Gain-of-function mutations in the tumor suppressor gene p53","volume":"6","author":"van Oijen","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.fct.2022.113321_bib91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-319-91287-5_27","article-title":"Hypoxia-\/HIF-1alpha-Driven factors of the tumor microenvironment impeding antitumor immune responses and promoting malignant progression","volume":"1072","author":"Vaupel","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.fct.2022.113321_bib93","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5134329","article-title":"Dendritic cells under hypoxia: how oxygen shortage affects the linkage between innate and adaptive immunity","author":"Winning","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.fct.2022.113321_bib94","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1089\/ars.2009.2541","article-title":"Redox-directed cancer therapeutics: molecular mechanisms and opportunities","volume":"11","author":"Wondrak","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.fct.2022.113321_bib95","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2150394","article-title":"Berberine ameliorates doxorubicin-induced cardiotoxicity via a SIRT1\/p66Shc-mediated pathway","author":"Wu","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.fct.2022.113321_bib96","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejmech.2012.01.033","article-title":"Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors","volume":"49","author":"Xia","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.fct.2022.113321_bib97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ebiom.2017.02.011","article-title":"Multiple myeloma tumor cells are selectively killed by pharmacologically-dosed ascorbic acid","volume":"18","author":"Xia","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.fct.2022.113321_bib98","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1389557517666170717125821","article-title":"Nutlin-3, A p53-mdm2 antagonist for nasopharyngeal carcinoma treatment","volume":"18","author":"Yee-Lin","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.fct.2022.113321_bib99","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.fct.2022.113321_bib100","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/med.21771","article-title":"The role of hypoxia-inducible factor 1 in tumor immune evasion","volume":"41","author":"You","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.fct.2022.113321_bib101","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jmb.2017.03.030","article-title":"Mutant p53 in cancer: accumulation, gain-of-function, and therapy","volume":"429","author":"Yue","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.fct.2022.113321_bib102","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.2147\/OTT.S222702","article-title":"High-dose vitamin C suppresses the invasion and metastasis of breast cancer cells via inhibiting epithelial-mesenchymal transition","volume":"12","author":"Zeng","year":"2019","journal-title":"OncoTargets Ther."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691522005191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691522005191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:19:40Z","timestamp":1759529980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691522005191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":91,"alternative-id":["S0278691522005191"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2022.113321","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin C-induced competitive binding of HIF-1\u03b1 and p53 to ubiquitin E3 ligase CBL contributes to anti-breast cancer progression through p53 deacetylation","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2022.113321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113321"}}